rishav.uni.ip

After spending years working in research labs covering drug discovery & healthcare AI and experiences in healthcare investing roles, I've seen how unnecessarily convoluted the path from bench to market is. University tech transfer offices are ill-equipped to market their technologies effectively, and the buy-side (R&D focused companies & investors) don't have access to a comprehensive database of technologies ready for licensing and tools to help them diligence what technologies are perfect f...